At some point in most chronic pain journeys, a provider offers an injection. Often it is a corticosteroid (cortisone) shot into a joint, an epidural space, or a trigger point. For many patients this is where the conversation about treatment options stops. The shot helps for a while. Then the pain returns. Another shot is offered. The cycle repeats.
That pattern is worth examining because the two classes of injection, corticosteroids and regenerative biologics, work through entirely different mechanisms and serve different goals. Understanding the difference will not tell you which one is right for your specific situation. That requires an evaluation. But it should change the questions you are asking before the next needle goes in.
Why Cortisone Became the Default Answer
Corticosteroid injections have been used in medicine for decades. They are familiar to most providers, covered by most insurance plans, and they demonstrably work in the short term for many conditions. A well-placed cortisone shot into an inflamed facet joint, a swollen knee, or an irritated bursa can produce meaningful relief within a few days and sometimes last several months.
That track record, combined with low upfront cost and broad insurance coverage, made cortisone the go-to option. It fits neatly into a short office visit. It can be billed easily. And for patients who are not candidates for surgery but are in real pain, it offers a path to functional relief without a major procedure.
The problem is not that cortisone does not work. The problem is that it is often presented as a treatment rather than what it actually is: a symptom manager.
What a Corticosteroid Injection Actually Does
Cortisone reduces inflammation. That is genuinely useful. But inflammation is often a sign that something structural is under stress. Reducing the signal does not change what is creating the stress.
Corticosteroids work by suppressing the local immune and inflammatory response. When injected into a joint, they reduce swelling, decrease prostaglandin production, and quiet the pain signals traveling through the surrounding nerves. The relief is real and sometimes dramatic.
What cortisone does not do is repair cartilage, regenerate disc tissue, stimulate new collagen formation, or restore mechanical stability to a joint. It creates a window of reduced inflammation. What happens during that window, and whether the underlying structural problem is addressed, determines whether the relief sticks.
There is also a cumulative concern with repeated injections. The FDA and most orthopedic guidelines note that multiple corticosteroid injections into the same area over time can accelerate cartilage breakdown, weaken local tendons, and in some cases worsen the degeneration they were meant to palliate. Most providers recommend limiting injections to three or four per year in a given site, though practices vary.
None of this makes cortisone a bad treatment. It makes it a specific tool with a specific purpose, appropriate limitations, and a finite window of usefulness for any individual joint or structure.
What "Regenerative Medicine" Actually Means
Regenerative medicine is a broad term that covers several different therapies, and it is worth being precise because the category includes treatments of very different maturity levels.
The most established and widely used regenerative options in musculoskeletal care include:
- Platelet-rich plasma (PRP): A concentration of the patient's own platelets, drawn from a blood sample and injected into the treatment site. Platelets carry growth factors that signal tissue repair. PRP has a reasonable body of evidence for knee osteoarthritis, certain tendon injuries, and some spinal applications, though results vary by concentration protocol and injection technique.
- Bone marrow aspirate concentrate (BMAC): Stem cells drawn from the patient's own bone marrow (typically the iliac crest) and reinjected into a target area. Contains mesenchymal stem cells that can theoretically differentiate into cartilage, bone, or connective tissue depending on the local environment.
- Exosome and extracellular vesicle therapies: Newer and still largely investigational in the US. Exosomes are signaling molecules derived from stem cells; they do not contain living cells but carry the molecular messages those cells use to trigger repair cascades.
- Allogeneic stem cell therapies: Cells derived from donor tissue (most often umbilical cord or Wharton's jelly). These are the therapies more commonly available at licensed facilities in countries like Colombia, where regulatory pathways for advanced biologics differ from the FDA's current framework.
The central claim of regenerative medicine is that instead of suppressing inflammation, these therapies try to recruit and accelerate the body's own repair processes. The goal is tissue restoration, not signal suppression.
What the evidence does not yet support, and what no credible provider should promise, is that any of these treatments is a guaranteed fix or a permanent cure for a degenerative joint. What the evidence does support, across a growing number of trials, is that in well-selected patients, regenerative injections can produce longer-lasting functional improvement than cortisone and may slow the progression of degeneration rather than accelerating it.
Why Some Patients Travel to Colombia for Stem Cell Therapy
The FDA regulates cell therapies in the United States under 21 CFR Part 1271. Under current guidance, most allogeneic stem cell therapies (those using cells from a donor rather than the patient's own body) are classified as biological drugs requiring an Investigational New Drug (IND) application and clinical trial approval before they can be administered outside of a study setting. That regulatory framework exists to protect patients and is legitimate. It also means that most of the advanced stem cell protocols used clinically in other countries are not yet legally available in standard US clinical practice.
Colombia has developed a licensed, regulated framework for advanced regenerative treatments at accredited medical facilities. The regulatory pathway there permits administration of certain allogeneic biologics in a clinical setting under physician oversight, which is not currently the case at most US outpatient clinics.
At Spine and Wellness Center Lakewood Ranch, we have a direct partnership with a licensed facility in Colombia. Patients who are evaluated here and found to be candidates for advanced stem cell therapy can be referred and coordinated through that partnership. This is not medical tourism in the informal sense. It is a structured referral pathway with pre-treatment evaluation, coordination of care, and follow-up management back here in Lakewood Ranch.
Not every patient is a candidate for this level of intervention. Many patients do extremely well with PRP, spinal decompression, laser therapy, or a structured chiropractic and rehabilitation program. Our regenerative medicine page outlines how we approach candidacy evaluation. The point is that for the right patient, especially someone who has exhausted conventional options and is facing a joint replacement they are not ready for, an advanced regenerative option through an accredited international partner may represent a meaningful step that simply is not available locally.
Cortisone vs Regenerative: Who Benefits from Each
These treatments are not interchangeable, and for many patients the question is not one versus the other but when and in what combination.
Cortisone tends to be appropriate when:
- Acute inflammatory flare is limiting participation in physical therapy or rehabilitation.
- The goal is short-term pain control to enable function while a longer-term plan is executed.
- The joint or structure involved has not yet received multiple previous injections.
- The patient needs relief in order to tolerate other interventions (decompression, exercise, manipulation).
Regenerative options tend to be more appropriate when:
- Cortisone has provided diminishing relief over multiple cycles.
- There is evidence of cartilage loss, disc degeneration, or tendon damage that cortisone cannot address structurally.
- The patient is trying to defer or avoid a surgical procedure such as a total knee replacement, spinal fusion, or rotator cuff repair.
- The patient is in good enough health that tissue repair capacity is reasonable (younger biological age, non-smoker, adequate nutrition).
- The goal is functional restoration over a 6 to 18-month horizon, not just the next three months.
For patients dealing with lumbar disc pain and associated sciatica, the picture is more nuanced. Epidural steroid injections (cortisone into the epidural space) can provide meaningful temporary relief of nerve root irritation. But for a disc that has lost significant height and is mechanically unstable, spinal decompression combined with a regenerative protocol is often a more logical long-term strategy than repeated epidurals.
The Questions to Ask Before Your Next Injection
Regardless of which type of injection is being offered, these are the questions worth raising before proceeding:
- What is the injection designed to do? Reduce inflammation? Promote tissue repair? Both? Understanding the mechanism helps you evaluate the expected outcome.
- How many times have I had this type of injection in this location? If you are at three or more cortisone injections in the same site, the risk-benefit calculus changes.
- What is the plan for the structural problem driving the inflammation? If cortisone is being used as a bridge, what is it bridging to?
- Has the source of the pain been confirmed? Not all knee pain comes from the knee. Not all shoulder pain comes from the rotator cuff. An injection placed in the wrong location or targeting the wrong structure will not help regardless of what is in the syringe.
- Am I a candidate for a regenerative option? If you have not had this conversation with a provider who offers it, you may not have been given the full picture.
These are not adversarial questions. A good provider will welcome them. The goal is to make sure the treatment matches your actual clinical situation rather than defaulting to the most familiar or most reimbursable option.
How We Approach This at Spine and Wellness Center
Our starting point is always an evaluation of what is structurally driving the pain. For many patients with chronic back pain, that means understanding the disc status, the nerve root involvement, and the mechanical loading pattern before any injection decision is made.
From there, a care plan might include spinal decompression to address disc pressure directly, Class IV laser to support soft-tissue healing, chiropractic adjustment to restore joint mechanics, and in appropriate cases, a PRP protocol or a referral through our Colombia partnership for advanced cell therapy. The tools are not competing; they are sequenced to match what the tissue actually needs at each stage of recovery.
Cortisone has a place in that toolkit. So do regenerative options. What matters is the reasoning behind the choice, not a preference for one category over another.
If you have been on a cortisone injection cycle that is providing less relief over time, or if you are trying to understand your options before agreeing to a surgical recommendation, we are glad to give you a structural evaluation and a frank conversation about what is realistic. Reach out at (727) 213-2982 or book directly at the link below.
